Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) – Stock analysts at Wedbush issued their FY2027 earnings per share (EPS) estimates for shares of Fennec Pharmaceuticals in a research report issued to clients and investors on Thursday, May 11th. Wedbush analyst D. Nierengarten forecasts that the biopharmaceutical company will post earnings of $3.38 per share for […]
Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) – Equities researchers at HC Wainwright cut their Q1 2023 EPS estimates for Fennec Pharmaceuticals in a research note issued to investors on Tuesday, April 4th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post earnings of ($0.27) per share for the quarter, down […]
Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) – Equities research analysts at Wedbush boosted their FY2024 earnings estimates for Fennec Pharmaceuticals in a research note issued to investors on Thursday, March 30th. Wedbush analyst D. Nierengarten now expects that the biopharmaceutical company will post earnings of $0.20 per share for the year, up from their […]
Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) – Equities researchers at Wedbush upped their FY2024 earnings estimates for shares of Fennec Pharmaceuticals in a research note issued on Thursday, May 12th. Wedbush analyst D. Nierengarten now expects that the biopharmaceutical company will post earnings of $0.91 per share for the year, up from their previous […]
Shares of Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$6.62 and traded as high as C$7.52. Fennec Pharmaceuticals shares last traded at C$7.52, with a volume of 106 shares. Separately, Maxim Group reaffirmed a […]